NOACs Added to WHO’s Essential Medicines List: Recommendations for Future Policy Actions

The introduction of non-vitamin K antagonists oral anticoagulants, a class of medicines which includes dabigatran, apixaban, edoxaban and rivaroxaban, has resulted in improvements in the safety and efficacy of non valvular atrial fibrillation treatment for stroke prevention, with significant reducti...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Glob Heart
Main Authors: Di Cesare, Mariachiara, Jarvis, Jordan D., Scarlatescu, Oana, Leng, Xinyi, Zaidel, Ezequiel J., Burrone, Esteban, Eiselé, Jean-Luc, Prabhakaran, Dorairaj, Sliwa, Karen
Formato: Artigo
Idioma:Inglês
Publicado: Ubiquity Press 2020
Assuntos:
Editorial
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7546116/
https://ncbi.nlm.nih.gov/pubmed/33150132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5334/gh.774
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares